CN101167763A - 一种防治心脑血管疾病的红曲和银杏总内酯组合物 - Google Patents
一种防治心脑血管疾病的红曲和银杏总内酯组合物 Download PDFInfo
- Publication number
- CN101167763A CN101167763A CNA2007101334762A CN200710133476A CN101167763A CN 101167763 A CN101167763 A CN 101167763A CN A2007101334762 A CNA2007101334762 A CN A2007101334762A CN 200710133476 A CN200710133476 A CN 200710133476A CN 101167763 A CN101167763 A CN 101167763A
- Authority
- CN
- China
- Prior art keywords
- monas cuspurpureus
- cuspurpureus went
- ginkgo total
- pharmaceutical composition
- total lactones
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000002526 effect on cardiovascular system Effects 0.000 title claims abstract description 19
- 208000024172 Cardiovascular disease Diseases 0.000 title claims abstract description 15
- 208000026106 cerebrovascular disease Diseases 0.000 title claims abstract description 14
- 239000000203 mixture Substances 0.000 title abstract description 19
- 241000228347 Monascus <ascomycete fungus> Species 0.000 title abstract 2
- 229930184727 ginkgolide Natural products 0.000 title 1
- 239000003814 drug Substances 0.000 claims abstract description 27
- MOLPUWBMSBJXER-YDGSQGCISA-N bilobalide Chemical compound O([C@H]1OC2=O)C(=O)[C@H](O)[C@@]11[C@@](C(C)(C)C)(O)C[C@H]3[C@@]21CC(=O)O3 MOLPUWBMSBJXER-YDGSQGCISA-N 0.000 claims abstract description 10
- 238000002360 preparation method Methods 0.000 claims abstract description 5
- 235000013373 food additive Nutrition 0.000 claims abstract description 4
- 239000002778 food additive Substances 0.000 claims abstract description 4
- 235000002322 Monascus purpureus Nutrition 0.000 claims description 63
- 244000113306 Monascus purpureus Species 0.000 claims description 63
- 229940057059 monascus purpureus Drugs 0.000 claims description 63
- 150000002596 lactones Chemical class 0.000 claims description 48
- 241000218628 Ginkgo Species 0.000 claims description 44
- 235000011201 Ginkgo Nutrition 0.000 claims description 44
- 235000008100 Ginkgo biloba Nutrition 0.000 claims description 44
- 239000000284 extract Substances 0.000 claims description 31
- 239000008194 pharmaceutical composition Substances 0.000 claims description 12
- 229940079593 drug Drugs 0.000 claims description 5
- 230000002265 prevention Effects 0.000 claims description 3
- 239000003937 drug carrier Substances 0.000 claims description 2
- 235000013402 health food Nutrition 0.000 claims description 2
- 239000002994 raw material Substances 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 14
- 230000000694 effects Effects 0.000 description 13
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 8
- 239000007924 injection Substances 0.000 description 7
- 238000002347 injection Methods 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 241000700159 Rattus Species 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- 238000004220 aggregation Methods 0.000 description 4
- 230000002776 aggregation Effects 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- 239000006187 pill Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 150000003626 triacylglycerols Chemical class 0.000 description 4
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical group [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 210000001772 blood platelet Anatomy 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 238000010828 elution Methods 0.000 description 3
- 229960005139 epinephrine Drugs 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- 239000008215 water for injection Substances 0.000 description 3
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 2
- 229930182837 (R)-adrenaline Natural products 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 238000004040 coloring Methods 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 229940008099 dimethicone Drugs 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 2
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- 238000002481 ethanol extraction Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 229930182486 flavonoid glycoside Natural products 0.000 description 2
- 150000007955 flavonoid glycosides Chemical class 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 238000009413 insulation Methods 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- -1 washing Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 1
- 239000005541 ACE inhibitor Substances 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 101710129690 Angiotensin-converting enzyme inhibitor Proteins 0.000 description 1
- 101710086378 Bradykinin-potentiating and C-type natriuretic peptides Proteins 0.000 description 1
- 229940127291 Calcium channel antagonist Drugs 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 229940097420 Diuretic Drugs 0.000 description 1
- 102000015779 HDL Lipoproteins Human genes 0.000 description 1
- 108010010234 HDL Lipoproteins Proteins 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical class OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 description 1
- 239000000006 Nitroglycerin Substances 0.000 description 1
- 241001597008 Nomeidae Species 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 206010049418 Sudden Cardiac Death Diseases 0.000 description 1
- 229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 239000002876 beta blocker Substances 0.000 description 1
- 229940097320 beta blocking agent Drugs 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000000480 calcium channel blocker Substances 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- 239000007919 dispersible tablet Substances 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 229960003711 glyceryl trinitrate Drugs 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- TZBAVQKIEKDGFH-UHFFFAOYSA-N n-[2-(diethylamino)ethyl]-1-benzothiophene-2-carboxamide;hydrochloride Chemical compound [Cl-].C1=CC=C2SC(C(=O)NCC[NH+](CC)CC)=CC2=C1 TZBAVQKIEKDGFH-UHFFFAOYSA-N 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920006122 polyamide resin Polymers 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000003087 receptor blocking agent Substances 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000007779 soft material Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000001732 thrombotic effect Effects 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
组别 | 鼠数(只) | 15min内恢复数(只) | 恢复率(%) |
生理盐水组 | 20 | 0 | 0 |
银杏叶注射液组 | 20 | 10 | 60.0 |
红曲提取物 | 20 | 8 | 40.0 |
银杏总内酯 | 20 | 13 | 65.0 |
红曲-银杏总内酯200∶1组 | 20 | 14 | 70.0 |
红曲-银杏总内酯50∶1组 | 20 | 14 | 70.0 |
红曲提取物-银杏总内酯20∶1组 | 20 | 18 | 90.0 |
红曲-银杏总内酯10∶1组 | 20 | 19 | 95.0 |
红曲提取物-银杏总内酯5∶1组 | 20 | 16 | 80.0 |
红曲提取物-银杏总内酯2∶1组 | 20 | 14 | 70.0 |
组别 | 圆树型(%) | 扩大型(%) | 聚集数(个) | |||
给药前 | 给药后 | 给药前 | 给药后 | 给药前 | 给药后 | |
生理盐水组 | 70.7±4.18 | 72.5±1.21 | 29.8±4.23 | 28.2±1.19 | 62.7±4.02 | 59.3±3.50 |
银杏叶注射液组 | 71.5±3.48 | 78.3±2.86 | 30.7±2.73 | 28.4±2.79 | 63.2±3.83 | 57.0±4.32 |
红曲提取物组 | 72.3±4.15 | 78.9±2.56 | 29.3±4.58 | 27.5±4.19 | 63.6±4.19 | 57.3±4.49 |
银杏总内酯组 | 71.6±2.79 | 80.5±4.38 | 29.3±5.17 | 28.4±2.84 | 64.9±5.05 | 54.7±5.74 |
红曲-银杏总内酯100∶1组 | 72.4±4.33 | 87.4±3.89 | 30.6±5.29 | 27.5±4.40 | 64.2±5.21 | 50.9±5.95 |
红曲-银杏总内酯50∶1组 | 69.7±3.17 | 90.3±6.81 | 28.8±5.16 | 30.9±3.64 | 62.7±5.73 | 43.5±7.37 |
红曲-银杏总内酯20∶1组 | 73.5±4.48 | 88.6±6.59 | 31.2±5.66 | 26.8±4.37 | 61.5±5.98 | 42.6±5.63 |
红曲-银杏总内酯10∶1组 | 72.7±5.75 | 86.8±5.81 | 30.1±4.85 | 28.2±6.08 | 62.4±4.17 | 46.1±4.88 |
红曲-银杏总内酯5∶1组 | 70.3±3.19 | 82.4±4.20 | 29.7±4.29 | 28.4±3.53 | 61.6±4.16 | 44.8±5.45 |
红曲-银杏总内酯2∶1组 | 71.4±3.98 | 80.8±4.71 | 30.5±4.49 | 28.3±3.62 | 62.5±5.03 | 52.5±4.60 |
组别 | 鼠数(只) | TC | TG | HDL-C |
0′组 | 15 | 46.2±5.1 | 51.1±18.3 | 29.6±5.4 |
0组 | 15 | 98.5±21.0 | 248.1±75.2 | 21.5±1.8 |
红曲提取物 | 15 | 86.8±14.7 | 142.7±16.9 | 24.1±4.6 |
红曲-银杏总内酯20∶1组 | 15 | 77.5±13.5 | 136.9±20.3 | 22.6±3.3 |
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007101334762A CN101167763B (zh) | 2007-09-29 | 2007-09-29 | 一种防治心脑血管疾病的红曲和银杏总内酯组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007101334762A CN101167763B (zh) | 2007-09-29 | 2007-09-29 | 一种防治心脑血管疾病的红曲和银杏总内酯组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101167763A true CN101167763A (zh) | 2008-04-30 |
CN101167763B CN101167763B (zh) | 2010-06-09 |
Family
ID=39388611
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2007101334762A Expired - Fee Related CN101167763B (zh) | 2007-09-29 | 2007-09-29 | 一种防治心脑血管疾病的红曲和银杏总内酯组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101167763B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103404759A (zh) * | 2013-05-27 | 2013-11-27 | 胡安然 | 一种冠心病患者食用的特殊膳食 |
CN107952003A (zh) * | 2017-10-24 | 2018-04-24 | 深圳市麦金利实业有限公司 | 一种银杏叶红曲保健品及其制备方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100336517C (zh) * | 2005-07-29 | 2007-09-12 | 南京海陵中药制药工艺技术研究有限公司 | 预防或治疗心脑血管疾病的红曲、银杏叶组合物及其应用 |
-
2007
- 2007-09-29 CN CN2007101334762A patent/CN101167763B/zh not_active Expired - Fee Related
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103404759A (zh) * | 2013-05-27 | 2013-11-27 | 胡安然 | 一种冠心病患者食用的特殊膳食 |
CN107952003A (zh) * | 2017-10-24 | 2018-04-24 | 深圳市麦金利实业有限公司 | 一种银杏叶红曲保健品及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN101167763B (zh) | 2010-06-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102895432A (zh) | 开心散新剂型处方工艺及其制备方法 | |
CN101612362B (zh) | 一种调节血脂、防治心脑血管疾病复方制剂及其制备方法 | |
CN100366280C (zh) | 一种治疗高血压的药物组合物及其制备方法和用途 | |
CN101297889A (zh) | 治疗口蹄疫的中药制剂及其制备方法 | |
CN101780158B (zh) | 一种具有降血压功能的中药组合物及其制备方法 | |
CN108619355A (zh) | 一种抗肿瘤中药组合物及其制备方法 | |
CN101167763B (zh) | 一种防治心脑血管疾病的红曲和银杏总内酯组合物 | |
CN1799582A (zh) | 降血糖、降血压的药物 | |
CN102895387B (zh) | 一种温补肾阳的药物组合物、制剂及其制备方法 | |
CN104922295A (zh) | 一种养血、补血的中药组合物 | |
CN101167796B (zh) | 一种防治心脑血管疾病的红曲和丹参组合物 | |
CN102641357A (zh) | 一种治疗高血压的药物及其制备方法 | |
CN102204956B (zh) | 一种用于中风恢复期的中药组合物及其制备方法 | |
CN104258034A (zh) | 一种增强免疫力的中药组合物 | |
CN113940971B (zh) | 一种治疗睡眠障碍的中药颗粒剂及其制备方法 | |
CN115300554B (zh) | 一种活血通络的中药制剂及其制备方法 | |
CN107375913A (zh) | 一种负载纳豆激酶的血栓通络药物及其制备方法 | |
CN102895433A (zh) | 读书丸新剂型处方工艺及其制备方法 | |
CN108815342B (zh) | 一种治疗男性不育的中药组合物 | |
CN103181962A (zh) | 用于治疗中风后遗症的中药泡腾颗粒及其制备方法 | |
CN102631506B (zh) | 提高免疫力、抗疲劳的中药组合物 | |
CN101816708A (zh) | 治疗风湿病的中药组合物及其制备方法 | |
CN106361829A (zh) | 治疗缺血性中风的中药组合物、制剂及其制备方法 | |
CN102058668A (zh) | 一种治疗原发性血小板减少的中药制剂 | |
CN105687567A (zh) | 防治化疗引起的腹泻的制剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
C41 | Transfer of patent application or patent right or utility model | ||
PB01 | Publication | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20080229 Address after: Guangdong city of Guangzhou province Haizhuqu District Quanjude road 1751 No. three layer S5 room Applicant after: Guangzhou Jiake Biotechnology Co., Ltd. Address before: Dirt road, Jiangning District, Nanjing, Jiangsu Applicant before: Nanjing Kewen Biological Technology Co., Ltd. |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: JIANGSU YINGKE BIOPHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: GUANGZHOU JIAKE BIOTECHNOLOGY CO., LTD. Effective date: 20121213 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 510310 GUANGZHOU, GUANGDONG PROVINCE TO: 225300 TAIZHOU, JIANGSU PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20121213 Address after: 225300 G41 workshop, Chinese medicine city, Taizhou, Jiangsu Patentee after: JIANGSU YINGKE BIOLOGICAL PHARMACEUTICAL CO., LTD. Address before: Three S5 room, 17-51 floor, 510310 Jude Road, Guangzhou, Haizhuqu District, Guangdong Patentee before: Guangzhou Jiake Biotechnology Co., Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100609 Termination date: 20170929 |
|
CF01 | Termination of patent right due to non-payment of annual fee |